We previously demonstrated that reducing Scn8a expression is therapeutic in Scn1a+/− mice (Lenk et al., 2020) and in mice with epilepsy caused by loss of the potassium channel genes Kcna1 and Kcnq2 (Hill et al., 2022). This evidence concerns the gene SCN8A and epilepsy.